|
|
|
|
| LEADER |
00000cam a2200000Ma 4500 |
| 001 |
EBSCO_ocm42329097 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
931027s1993 dcua ob 001 0 eng d |
| 010 |
|
|
|z 93085360
|
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCL
|d OCLCQ
|d YDXCP
|d OCLCQ
|d NTE
|d OCLCQ
|d TUU
|d OCLCQ
|d TNF
|d OCLCQ
|d UV0
|d CUSER
|d E7B
|d IDEBK
|d CUS
|d WVH
|d OCLCQ
|d OCLCO
|d DKDLA
|d OCLCQ
|d COO
|d NLGGC
|d OCLCQ
|d AZK
|d OCLCQ
|d VT2
|d MWM
|d OCLCO
|d TOA
|d OCLCO
|d AGLDB
|d MOR
|d PIFBR
|d XFH
|d OCLCQ
|d OCLCA
|d U3W
|d OCLCA
|d OCLCQ
|d BUF
|d OCLCO
|d LUE
|d STF
|d WRM
|d OCLCQ
|d VTS
|d COCUF
|d OCLCO
|d TOF
|d NRAMU
|d INT
|d OCLCQ
|d AU@
|d OCLCQ
|d WYU
|d OCLCQ
|d UKAHL
|d M8D
|d KIJ
|d UKBTH
|d DST
|d AAA
|d OCLCO
|d OCLCF
|d LUU
|d TNZ
|d INARC
|d OCLCA
|d OCLCQ
|d CJT
|d OCLCQ
|
| 019 |
|
|
|a 228064163
|a 326709854
|a 647367446
|a 666928803
|a 698448129
|a 722262434
|a 888492662
|a 961491743
|a 961609004
|a 962577092
|a 962699550
|a 970749169
|a 988468854
|a 992074398
|a 994498766
|a 1037908569
|a 1038582312
|a 1045521185
|a 1059036018
|a 1062938301
|a 1081187501
|a 1097105128
|a 1156385905
|a 1159618591
|a 1228617756
|a 1241811389
|a 1249226893
|a 1259237770
|a 1290107936
|a 1300595087
|a 1303388202
|a 1303459810
|a 1306560528
|a 1373446960
|a 1378240696
|a 1397471641
|
| 020 |
|
|
|a 0585024782
|q (electronic bk.)
|
| 020 |
|
|
|a 9780585024783
|q (electronic bk.)
|
| 020 |
|
|
|a 1280196025
|
| 020 |
|
|
|a 9781280196027
|
| 020 |
|
|
|a 9786610196029
|
| 020 |
|
|
|a 6610196028
|
| 020 |
|
|
|a 0309598354
|
| 020 |
|
|
|a 9780309598354
|
| 020 |
|
|
|z 0309049490
|
| 020 |
|
|
|z 9780309049498
|q (pbk.)
|
| 029 |
1 |
|
|a AU@
|b 000051468697
|
| 029 |
1 |
|
|a AU@
|b 000053229033
|
| 029 |
1 |
|
|a DEBBG
|b BV043084118
|
| 029 |
1 |
|
|a DEBSZ
|b 422621048
|
| 029 |
1 |
|
|a GBVCP
|b 800495659
|
| 029 |
1 |
|
|a NZ1
|b 11927654
|
| 029 |
1 |
|
|a NZ1
|b 16067714
|
| 035 |
|
|
|a (OCoLC)42329097
|z (OCoLC)228064163
|z (OCoLC)326709854
|z (OCoLC)647367446
|z (OCoLC)666928803
|z (OCoLC)698448129
|z (OCoLC)722262434
|z (OCoLC)888492662
|z (OCoLC)961491743
|z (OCoLC)961609004
|z (OCoLC)962577092
|z (OCoLC)962699550
|z (OCoLC)970749169
|z (OCoLC)988468854
|z (OCoLC)992074398
|z (OCoLC)994498766
|z (OCoLC)1037908569
|z (OCoLC)1038582312
|z (OCoLC)1045521185
|z (OCoLC)1059036018
|z (OCoLC)1062938301
|z (OCoLC)1081187501
|z (OCoLC)1097105128
|z (OCoLC)1156385905
|z (OCoLC)1159618591
|z (OCoLC)1228617756
|z (OCoLC)1241811389
|z (OCoLC)1249226893
|z (OCoLC)1259237770
|z (OCoLC)1290107936
|z (OCoLC)1300595087
|z (OCoLC)1303388202
|z (OCoLC)1303459810
|z (OCoLC)1306560528
|z (OCoLC)1373446960
|z (OCoLC)1378240696
|z (OCoLC)1397471641
|
| 050 |
|
4 |
|a RG137.6.M53
|b C57 1993eb
|
| 060 |
|
4 |
|a 1994 B-064
|
| 060 |
|
4 |
|a QV 175 C641 1993
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.766
|2 20
|
| 084 |
|
|
|a XI 5203
|2 rvk
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Clinical applications of mifepristone (RU 486) and other antiprogestins :
|b assessing the science and recommending a research agenda /
|c Committee on Antiprogestins: Assessing the Science, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Molla S. Donaldson [and others], editors.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academy Press,
|c 1993.
|
| 300 |
|
|
|a 1 online resource (xi, 288 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 500 |
|
|
|a "Support for this project was provided by a grant from the Henry J. Kaiser Family Foundation, Menlo Park, California."--Title page verso.
|
| 500 |
|
|
|a Committee chairman: Leslie Z. Benet.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Background and historical perspectives -- IOM report -- Cross-cutting recommendations -- Uses of antiprogestins: the reproductive cycle -- Contraception -- Post-coital contraception -- Menses induction -- Uses of antiprogestins: the reproductive cycle -- Pregnancy termination during the first trimester -- Pregnancy termination during the second trimester -- Cervical ripening -- Labor induction in late pregnancy -- Other therapeutic uses of antiprogestins -- Endometriosis -- Uterine leiomyomas (fibroids) -- Breast cancer -- Meningiomas -- Antiglucocorticoid effects of antiprogestins -- Glucocorticoid function -- Therapeutic use of mifepristone (RU 486) as an antiglucocorticoid -- Adverse antiglucocorticoid effects of antiprogestins -- Animals as models for studying antiprogestins -- Agenda for the IOM workshop "Antiprogestins: Assessing the Science" -- Background papers and presentations (in order of presentation at IOM workshop) -- 1993: RU 486: a decade on today and tomorrow / Etienne-Emile Baulieu.
|
| 505 |
0 |
|
|a (cont) Overview and background: mechanism of action of antiprogestins / Nancy L. Weigel -- Use of antiprogestins in the reproductive cycle / Lynnette Kaye Nieman -- Potential contraceptive effects of antigestogens / David T. Baird -- Use of antiprogestins before 63 days of amenorrhea / Marc Bygdeman -- Uses of antiprogestins after 63 days of amenorrhea / Ancre Ulmann and Louise Silvestre -- Comments on session II -- David Grimes -- Use of antiprogestins in the management of endometriosis and leiomyoma / Samuel S.C. Yen -- Antiprogestins and the treatment of breast cancer / Kathryn B. Horwitz -- Uses of RU 486 as an antiglucocorticoid / Lynnette Kaye Nieman -- Primate models for the study of antiprogestins in reproductive medicine / Gary D. Hodgen -- Antiprogestogens: perspectives from a global research program / P.F.A. Van Look and H. von Hertzen -- Observers at the workshop on antiprogestins.
|
| 588 |
0 |
|
|a Print version record.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Mifepristone
|x Research.
|
| 650 |
|
0 |
|a Abortifacients
|x Research.
|
| 650 |
|
0 |
|a Progesterone
|x Antagonists
|x Research.
|
| 650 |
|
0 |
|a Mifepristone.
|
| 650 |
|
0 |
|a Abortifacients.
|
| 650 |
1 |
2 |
|a Mifepristone
|
| 650 |
1 |
2 |
|a Abortifacient Agents
|
| 650 |
2 |
2 |
|a Progesterone
|x antagonists & inhibitors
|
| 650 |
|
6 |
|a Mifépristone
|x Recherche.
|
| 650 |
|
6 |
|a Abortifs
|x Recherche.
|
| 650 |
|
6 |
|a Antiprogestérones
|x Recherche.
|
| 650 |
|
6 |
|a Mifépristone.
|
| 650 |
|
6 |
|a Abortifs.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Abortifacients.
|2 fast
|0 (OCoLC)fst00794580
|
| 650 |
|
7 |
|a Mifepristone.
|2 fast
|0 (OCoLC)fst01020660
|
| 650 |
|
7 |
|a RU 486
|2 gnd
|
| 650 |
0 |
7 |
|a RU 486.
|2 swd
|
| 700 |
1 |
|
|a Benet, Leslie Z.
|
| 700 |
1 |
|
|a Donaldson, Molla S.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee on Antiprogestins: Assessing the Science.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Division of Health Promotion and Disease Prevention.
|
| 776 |
0 |
8 |
|i Print version:
|t Clinical applications of mifepristone (RU 486) and other antiprogestins.
|d Washington, D.C. : National Academy Press, 1993
|z 0309049490
|w (DLC) 93085360
|w (OCoLC)28761657
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36567580
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10056944
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 783
|
| 938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 19602
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 2302888
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 6013090
|
| 938 |
|
|
|a Internet Archive
|b INAR
|n clinicalapplicat0000unse_y1v7
|
| 994 |
|
|
|a 92
|b IZTAP
|
